He spearheaded the Red Hat acquisition in 2019 that began IBM's comeback, and since becoming CEO in 2020, he has built on ...
Chevening Scholarship 2026: Applications will be accepted from August 5, 2025, until October 7, 2025, for the 2025–2026 academic year. By June 2026, it should be completed. The rigorous selection ...
Bayer has filed for approval in the US for elinzanetant as a non-hormonal treatment for menopausal symptoms such as hot flushes, with a rival therapy from Astellas in its sights. The FDA submission is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback